{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:10:05Z","timestamp":1795043405573,"version":"4.10.2"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Background and Aims:<\/jats:title>\n            <jats:p>NAFLD comprises a spectrum of liver disorders with the initial abnormal accumulation of lipids in hepatocytes called NAFL, progressing to the more serious NASH in a subset of individuals. Our previous study revealed that global flavin-containing monooxygenase 2 (FMO2) knockout causes higher liver weight in rats. However, the role of FMO2 in NAFLD remains unclear. Herein, we aimed to determine the function and mechanism of FMO2 in liver steatosis and steatohepatitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Approach and Results:<\/jats:title>\n            <jats:p>The expression of FMO2 was significantly downregulated in patients with NAFL\/NASH and mouse models. Both global and hepatocyte-specific knockout of FMO2 resulted in increased lipogenesis and severe hepatic steatosis, inflammation, and fibrosis, whereas FMO2 overexpression in mice improved NAFL\/NASH. RNA sequencing showed that hepatic FMO2 deficiency is associated with impaired lipogenesis in response to metabolic challenges. Mechanistically, FMO2 directly interacts with SREBP1 at amino acids 217\u2013296 competitively with SREBP cleavage-activating protein (SCAP) and inhibits SREBP1 translocation from the endoplasmic reticulum (ER) to the Golgi apparatus and its subsequent activation, thus suppressing <jats:italic toggle=\"yes\">de novo<\/jats:italic> lipogenesis (DNL) and improving NAFL\/NASH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In hepatocytes, FMO2 is a novel molecule that protects against the progression of NAFL\/NASH independent of enzyme activity. FMO2 impairs lipogenesis in high-fat diet-induced or choline-deficient, methionine-deficient, amino acid-defined high-fat diet-induced steatosis, inflammation, and fibrosis by directly binding to SREBP1 and preventing its organelle translocation and subsequent activation. FMO2 thus is a promising molecule for targeting the activation of SREBP1 and for the treatment of NAFL\/NASH.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/hep.0000000000000643","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T14:00:30Z","timestamp":1698156030000},"page":"181-197","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":30,"title":["FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1"],"prefix":"10.1097","volume":"81","author":[{"given":"Changle","family":"Ke","sequence":"first","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchen","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianpeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyuan","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanna","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Nan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"},{"name":"Institute of Translational Medicine, College of Medicine, Zhejiang University, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, P.R.China"},{"name":"State Key Laboratory of Transvascular Implantation Devices, Hangzhou, P.R.China"},{"name":"Cardiovascular Key Laboratory of Zhejiang Province, Hangzhou, P.R.China"},{"name":"Research Center for Life Science and Human Health, Binjiang Institute of Zhejiang University, Hangzhou, P.R.China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"key":"R1-20250331","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20250331","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"R3-20250331","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S2468-1253(22)00008-5","article-title":"The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas","volume":"7","author":"D\u00edaz","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20250331","first-page":"1433","article-title":"Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: A meta-analysis of about 13 million individuals","volume":"77","author":"Mantovani","year":"2022","journal-title":"Gut"},{"key":"R5-20250331","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R6-20250331","doi-asserted-by":"crossref","first-page":"105484","DOI":"10.1016\/j.phrs.2021.105484","article-title":"Epigenetics in NAFLD\/NASH: Targets and therapy","volume":"167","author":"Sodum","year":"2021","journal-title":"Pharmacol Res"},{"key":"R7-20250331","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"Journal of Clinical Investigation"},{"key":"R8-20250331","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: Therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"R9-20250331","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J Hepatol"},{"key":"R10-20250331","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/CIRCRESAHA.122.320538","article-title":"FMO2 (Flavin Containing Monooxygenase 2) Prevents Cardiac Fibrosis via CYP2J3-SMURF2 Axis","volume":"131","author":"Ni","year":"2022","journal-title":"Circ Res"},{"key":"R11-20250331","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12986-020-00456-w","article-title":"High fat diet significantly changed the global gene expression profile involved in hepatic drug metabolism and pharmacokinetic system in mice","volume":"17","author":"He","year":"2020","journal-title":"Nutr Metab"},{"key":"R12-20250331","doi-asserted-by":"crossref","first-page":"888194","DOI":"10.3389\/fmolb.2022.888194","article-title":"Key genes associated with non-alcoholic fatty liver disease and polycystic ovary syndrome","volume":"9","author":"Chen","year":"2022","journal-title":"Front Mol Biosci"},{"key":"R13-20250331","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"},{"key":"R14-20250331","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"R15-20250331","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41467-022-28138-6","article-title":"Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis","volume":"13","author":"Lee","year":"2022","journal-title":"Nat Commun"},{"key":"R16-20250331","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/hep.32705","article-title":"Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression","volume":"77","author":"Ju\u00e1rez\u2010Fern\u00e1ndez","year":"2023","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R17-20250331","doi-asserted-by":"crossref","first-page":"eabe8939","DOI":"10.1126\/scitranslmed.abe8939","article-title":"Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors","volume":"13","author":"Cazanave","year":"2021","journal-title":"Science translational medicine"},{"key":"R18-20250331","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1038\/s41467-021-23958-4","article-title":"Measurement of lipogenic flux by deuterium resolved mass spectrometry","volume":"12","author":"Fu","year":"2021","journal-title":"Nat Commun"},{"key":"R19-20250331","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13238-020-00753-3","article-title":"POST1\/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation","volume":"12","author":"Xiao","year":"2021","journal-title":"Protein Cell"},{"key":"R20-20250331","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: Trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"R21-20250331","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-020-0476-2","article-title":"Aminoperoxide adducts expand the catalytic repertoire of flavin monooxygenases","volume":"16","author":"Matthews","year":"2020","journal-title":"Nat Chem Biol"},{"key":"R22-20250331","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2022.01.060","article-title":"Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine","volume":"594","author":"Shi","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"R23-20250331","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7498","article-title":"Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis","volume":"6","author":"Miao","year":"2015","journal-title":"Nat Commun"},{"key":"R24-20250331","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1210\/endrev\/bnz009","article-title":"Nonalcoholic fatty liver disease in adults: Current concepts in etiology, outcomes, and management","volume":"41","author":"Marjot","year":"2020","journal-title":"Endocr Rev"},{"key":"R25-20250331","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow","year":"2022","journal-title":"Cell Metab"},{"key":"R26-20250331","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molmed.2021.11.002","article-title":"Targeting ACC for NASH resolution","volume":"28","author":"Zhang","year":"2022","journal-title":"Trends Mol Med"},{"key":"R27-20250331","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/hep.32381","article-title":"Discovery of an insulin\u2010induced gene binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting sterol regulatory element\u2010binding protein\u2013mediated lipogenesis","volume":"76","author":"Jiang","year":"2022","journal-title":"Hepatology"},{"key":"R28-20250331","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1053\/j.gastro.2020.01.050","article-title":"Circadian rhythms in the pathogenesis and treatment of fatty liver disease","volume":"158","author":"Saran","year":"2020","journal-title":"Gastroenterology"},{"key":"R29-20250331","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2010.12.004","article-title":"Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques","volume":"13","author":"Tang","year":"2011","journal-title":"Cell Metab"},{"key":"R30-20250331","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s42255-022-00568-y","article-title":"Ammonia stimulates SCAP\/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumour growth","volume":"4","author":"Cheng","year":"2022","journal-title":"Nature Metabolism"},{"key":"R31-20250331","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s12276-020-0430-0","article-title":"The cellular function of SCAP in metabolic signaling","volume":"52","author":"Lee","year":"2020","journal-title":"Exp Mol Med"},{"key":"R32-20250331","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tibs.2021.12.005","article-title":"Structural advances in sterol-sensing domain-containing proteins","volume":"47","author":"Wu","year":"2022","journal-title":"Trends Biochem Sci"},{"key":"R33-20250331","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.cell.2021.05.019","article-title":"Scap structures highlight key role for rotation of intertwined luminal loops in cholesterol sensing","volume":"184","author":"Kober","year":"2021","journal-title":"Cell"},{"key":"R34-20250331","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","article-title":"Retrospective on cholesterol homeostasis: The central role of scap","volume":"87","author":"Brown","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"R35-20250331","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/jb\/mvu019","article-title":"A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid","volume":"155","author":"Nakakuki","year":"2014","journal-title":"The Journal of Biochemistry"},{"key":"R36-20250331","first-page":"1529","article-title":"Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression","volume":"38","author":"Sekiya","year":"2003","journal-title":"Hepatology"},{"key":"R37-20250331","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1074\/jbc.M007273200","article-title":"Unsaturated fatty acids down-regulate SREBP isoforms 1a and 1c by two mechanisms in HEK-293 cells","volume":"276","author":"Hannah","journal-title":"J Biol Chem"},{"key":"R38-20250331","doi-asserted-by":"crossref","first-page":"eabk2267","DOI":"10.1126\/scitranslmed.abk2267","article-title":"\u03b22-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development","volume":"13","author":"Rao","year":"2021","journal-title":"Science Translational Medicine"},{"key":"R39-20250331","doi-asserted-by":"crossref","first-page":"eabf8271","DOI":"10.1126\/science.abf8271","article-title":"Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1","volume":"376","author":"Gosis","year":"2022","journal-title":"Science"},{"key":"R40-20250331","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cell.2018.08.020","article-title":"Article ER stress drives lipogenesis and steatohepatitis via article ER stress drives lipogenesis and steatohepatitis via caspase-2 activation of S1P","volume":"175","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"R41-20250331","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/apt.13981","article-title":"Randomised clinical trial: The efficacy and safety of oltipraz, a liver X receptor alpha-inhibitory dithiolethione in patients with non-alcoholic fatty liver disease","volume":"45","author":"Kim","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R42-20250331","doi-asserted-by":"crossref","first-page":"e151895","DOI":"10.1172\/JCI151895","article-title":"Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis","volume":"132","author":"Kawamura","year":"2022","journal-title":"J Clin Invest"},{"key":"R43-20250331","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.3390\/ijms22189969","article-title":"Sex dimorphism of nonalcoholic fatty liver disease (NAFLD) in Pparg-null mice","volume":"22","author":"Schiffrin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R44-20250331","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1016\/j.celrep.2019.11.027","article-title":"Hypomorphic expression of Pitx3 disrupts circadian clocks and prevents metabolic entrainment of energy expenditure","volume":"29","author":"del R\u00edo-Mart\u00edn","year":"2019","journal-title":"Cell Reports"},{"key":"R45-20250331","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","article-title":"Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program","volume":"50","author":"Klarin","year":"2018","journal-title":"Nat Genet"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HEP.0000000000000643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T18:17:33Z","timestamp":1743445053000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HEP.0000000000000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/hep.0000000000000643","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]},"assertion":[{"value":"2023-05-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}